Taprenepag 100mg | ≥98%
CSNpharm
Taprenepag is an agonist of prostaglandin E2 receptor with EC50 of 2.8 nM with hypotensive activity.
More Information Supplier PageTaprenepag
Search Results
Taprenepag 10mg | ≥98%
CSNpharm
Taprenepag is an agonist of prostaglandin E2 receptor with EC50 of 2.8 nM with hypotensive activity.
More Information Supplier PageTaprenepag
Taprenepag 50mg | ≥98%
CSNpharm
Taprenepag is an agonist of prostaglandin E2 receptor with EC50 of 2.8 nM with hypotensive activity.
More Information Supplier PageTaprenepag
D-64131 50mg | ≥99%
CSNpharm
D-64131 is a novel tubulin polymerization inhibitor working by competitively binding with colchicine to αβ-tubulin.
More Information Supplier PageD-64131
D-64131 25mg | ≥99%
CSNpharm
D-64131 is a novel tubulin polymerization inhibitor working by competitively binding with colchicine to αβ-tubulin.
More Information Supplier PageD-64131
D-64131 10mg | ≥99%
CSNpharm
D-64131 is a novel tubulin polymerization inhibitor working by competitively binding with colchicine to αβ-tubulin.
More Information Supplier PageD-64131
Taprenepag 1mg | ≥98%
CSNpharm
Taprenepag is an agonist of prostaglandin E2 receptor with EC50 of 2.8 nM with hypotensive activity.
More Information Supplier PageTaprenepag
Taprenepag 5mg | ≥98%
CSNpharm
Taprenepag is an agonist of prostaglandin E2 receptor with EC50 of 2.8 nM with hypotensive activity.
More Information Supplier PageTaprenepag
Dinaciclib 10mg | ≥99%
CSNpharm
Dinaciclib is a potent CDK inhibitor for CDK2, CDK5, CDK1 and CDK9 with IC50 of 1 nM, 1 nM, 3 nM and 4 nM, respectively.
More Information Supplier PageDinaciclib
Dinaciclib 100mg | ≥99%
CSNpharm
Dinaciclib is a potent CDK inhibitor for CDK2, CDK5, CDK1 and CDK9 with IC50 of 1 nM, 1 nM, 3 nM and 4 nM, respectively.
More Information Supplier PageDinaciclib
